Related references
Note: Only part of the references are listed.Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture
Lucy Vulchanova et al.
MOLECULAR PAIN (2010)
Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood-Brain Barrier (BBB)
Steven J. Gray et al.
MOLECULAR THERAPY (2010)
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters
T. Husain et al.
GENE THERAPY (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Mojgan Rastegar et al.
PLOS ONE (2009)
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose
Zhijian Wu et al.
MOLECULAR THERAPY (2008)
Production and characterization of adeno-associated viral vectors
Joshua C. Grieger et al.
NATURE PROTOCOLS (2006)
A segment of the Mecp2 promoter is sufficient to drive expression in neurons
M Adachi et al.
HUMAN MOLECULAR GENETICS (2005)
Adeno-associated virus: from defective virus to effective vector
Manuel A. F. V. Goncalves
VIROLOGY JOURNAL (2005)
Recombinant AAV-mediated gene delivery to the central nervous system
L Tenenbaum et al.
JOURNAL OF GENE MEDICINE (2004)
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
AL Collins et al.
HUMAN MOLECULAR GENETICS (2004)
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
N Bessis et al.
GENE THERAPY (2004)
Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units
S Kügler et al.
VIROLOGY (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain
RL Klein et al.
EXPERIMENTAL NEUROLOGY (2002)
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
MD Shahbazian et al.
HUMAN MOLECULAR GENETICS (2002)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
JC Paterna et al.
GENE THERAPY (2000)
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
AM Peier et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
